How Trump's psychedelics executive order could unlock stalled cannabis reform
The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and iboga...
Last updated: 2026-04-20 19:35:25 ET
Pulse AI Brief
Updated Apr 20, 2026 7:00 PM ET
Psychedelic-focused biotech stocks rallied after President Trump signed an executive order aimed at expediting FDA review timelines for psychedelic-based treatments for mental illness. The regulatory acceleration removes a key bottleneck for clinical programs in psilocybin and MDMA-
The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and iboga... President Trump signed an executive order directing the FDA to speed up psychedelic drug reviews An executive order aims to speed up how quickly psychedelic drugs for mental illness can move through the regulatory process. 'lead a happier life' President Trump signed an executive order Saturday that eases restrictions on the research of the psychedelics including the drug ibogaine, which is u... President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaineDonald Trump on Saturday announced reforms in... Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs. The executive order will open the door for more research into the psychedelic drug ibogaine, sources told CBS News earlier this week. President Donald Trump on Saturday signed a sweeping executive order aimed at fast-tracking access to psychedelic-based treatments for veterans suffer... The president will direct federal agencies to boost research into the drugs and support clinical trials, moves championed by Robert F. Kennedy Jr.Mentions (24h)
Mentions (Range)
Sentiment (Avg / Median)
Sentiment Mix (Range)
Coverage Z-Score
Latest Articles on "psychedelic" (Range)
How Trump's psychedelics executive order could unlock stalled cannabis reform
President Trump signed an executive order directing the FDA to speed up psychedelic drug reviews
Psychedelic stocks rally with Trump’s support
Trump Signs Executive Order Speeding Up Research On Using Psychedelics For Mental Health
Watch: Trump signs executive order easing U.S. restrictions on psychedelic research
Trump announces reforms to accelerate access to psychedelic drug treatments
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
Trump signs order to research psychedelic used abroad to treat PTSD
Trump Cuts Wait For Breakthrough Mental Health Treatments For Veterans
Trump plans to ease access to psychedelics like psilocybin, ibogaine
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE